What did health officials recommend for COVID-19 vaccination in late 2020?

As the first COVID-19 vaccines became available in late 2020, a crucial question was: who should get them, and when? On December 12, 2020, the Advisory Committee on Immunization Practices (ACIP) — a group of medical experts that advises the U.S. Centers for Disease Control and Prevention — made an interim recommendation. They advised that the Pfizer-BioNTech COVID-19 vaccine could be used in people aged 16 years and older. This was a formal, procedural step in the national vaccine rollout, signaling that the committee had reviewed the available data and found it sufficient to move forward with vaccination for this age group. It's important to understand what this recommendation was and what it wasn't. It was an official green light for use based on the evidence available to the committee at that specific moment. The recommendation itself does not provide details on how well the vaccine worked, how safe it was, or how many people were involved in the studies that informed the decision. This snapshot from December 2020 captures a key moment in the pandemic response, but it's just one piece of a much larger and evolving story about COVID-19 vaccines.